Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Duspatalin® (Mebeverine Hydrochloride) 200 mg b.i.d. in Patients With Post-cholecystectomy Gastrointestinal Spasm: a Post Marketing Observational Program in the Russian Federation

NCT02260154 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT02260154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02260154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Duspatalin® (Mebeverine Hydrochloride) 200 mg b.i.d. in Patients With Post-cholecystectomy Gastrointestinal Spasm: a Post Marketing Observational Program in the Russian Federation
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
July 31, 2015
Completion date
October 31, 2016
Enrollment
220 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

post-cholecystectomy gastrointestinal spasms